Prediction of acute myeloid leukaemia risk in healthy individuals
2018 · Nature · 850 citations
https://doi.org/10.1038/s41586-018-0317-6
A
Alwin Krämer
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
272
Papers
12.6K
Citations
53
h-index
120
i10-index
Alwin Krämer is an academic researcher from German Cancer Research Center. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Microtubule and mitosis dynamics & Cancer Diagnosis and Treatment. The author has an h-index of 53, co-authored 232 publications.
Papers by this author
worksMolecularly guided therapy versus chemotherapy after disease control in unfavourable cancer of unknown primary (CUPISCO): an open-label, randomised, phase 2 study
2024 · The Lancet · 58 citations
https://doi.org/10.1016/s0140-6736(24)00814-6
Molecular docking and pharmacogenomics of Vinca alkaloids and their monomeric precursors, vindoline and catharanthine
2011 · Biochemical Pharmacology · 52 citations
https://doi.org/10.1016/j.bcp.2010.12.026
Lack of centrioles and primary cilia in<i>STIL<sup>−/−</sup></i>mouse embryos
2014 · Cell Cycle · 45 citations
https://doi.org/10.4161/15384101.2014.946830
Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial
2023 · Nature Communications · 31 citations
https://doi.org/10.1038/s41467-023-42400-5
Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation
2022 · Journal of Hematology & Oncology · 20 citations
https://doi.org/10.1186/s13045-022-01339-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat